-
PROTAC Nanoassemblies Potentiate FLASH Radiosensitization
2026-09-09
The reference study develops a folate-targeted, redox-responsive PROTAC nanoassembly that delivers ARV-771 to tumors and promotes BRD4 degradation during FLASH radiotherapy. Its findings connect BRD4-dependent DNA repair suppression with increased ROS, DNA double-strand breaks, apoptosis, and improved tumor control, while also identifying important requirements for translating the platform beyond the reported model.
-
Tetrahydromagnolol for GPCR Signaling Assays
2026-09-09
Tetrahydromagnolol offers a selective pharmacological entry point for CB2 receptor and cannabinoid signaling pathway studies. This article develops an evidence-calibrated framework for connecting CB2 pharmacology with GPCR-driven cytoskeletal assays without conflating distinct receptors or mechanisms.
-
HotStart Universal 2X FAST Green qPCR Guide
2026-09-08
HotStart Universal 2X FAST Green qPCR Master Mix is a ROX-containing, dye-based reagent for rapid and inhibitor-tolerant DNA or cDNA amplification. Its hot-start polymerase, Green I fluorescence, and recommended melt curve analysis support reproducible gene expression analysis while preserving the distinction between assay performance and biological interpretation.
-
Telmisartan in Cardiac Hypertrophy Research
2026-09-07
Telmisartan provides a defined AT1-receptor blockade strategy for separating angiotensin II-driven signaling from downstream RIP3/CaMKII remodeling. This practical guide covers solvent-aware preparation, hypertrophy workflows, orthogonal pathway readouts, and troubleshooting for cardiovascular disease research.
-
Grazoprevir hydrate: HCV Assay Workflows
2026-09-07
Build more informative HCV experiments by pairing NS3/4A target engagement with genotype-aware replication readouts and orthogonal controls. This guide shows how Grazoprevir hydrate, also known as MK-5172 hydrate, can support biochemical, replicon, resistance, and translational workflows.
-
Cdc42–β-Catenin Signaling in Kidney Fibrosis
2026-09-05
A 2024 Advanced Science study identified the natural diterpenoid daphnepedunin A as an anti-fibrotic lead that directly targets Cdc42. By reducing Cdc42 activity and downstream PKCζ/GSK-3β signaling, the compound promoted β-catenin degradation and reduced fibrotic responses in renal fibroblasts and a unilateral ureteral obstruction model.
-
MG-132 (Z-LLL-al): Proteasome Guide
2026-09-04
MG-132, also called Z-LLL-al, is a membrane-permeable peptide aldehyde used to inhibit proteasome activity in apoptosis assay, cell cycle, and cancer research workflows. Its vendor-reported activity is approximately 100 nM against the proteasome and 1.2 μM against calpain under assay conditions that should be confirmed experimentally.
-
DAPT (GSI-IX) Workflows for Notch Research
2026-09-04
DAPT (GSI-IX) gives researchers a practical way to connect γ-secretase activity with APP processing, Notch-dependent cell fate, and neuronal model design. This guide emphasizes dose-aware workflows, human sensory neuron applications, and troubleshooting that separates pathway effects from toxicity or assay drift.
-
L. plantarum P101 Activates AMPK Against Alcoholic Steatosis
2026-09-04
This 2025 mouse study integrated probiotic intervention, AMPK inhibition, gut microbiota profiling, and serum metabolomics to investigate how Lactiplantibacillus plantarum P101 limits alcohol-induced hepatic lipid accumulation. Its pharmacological blockade experiment supports AMPK activation as a mediator while the microbiome and metabolite findings generate testable hypotheses about gut–liver communication.
-
Homoharringtonine: From Ribosomes to Readiness
2026-09-03
Homoharringtonine offers translational researchers a compelling bridge between leukemia research and SARS-CoV-2 antiviral research. Its inhibition of eukaryotic protein synthesis provides a mechanistic rationale for activity across disease models, while recent animal and early patient evidence highlights both its promise and the need for disciplined validation.
-
GPR35–KLF5 Signaling in Epithelial Repair
2026-09-02
A 2026 Cell Death and Disease study identifies a tryptophan metabolic gatekeeping mechanism in which GPR35 senses changes in the tryptophan–kynurenine–kynurenic acid axis and activates KLF5-dependent epithelial repair. The work connects metabolite sensing to PI3K–AKT–mTOR signaling, providing a mechanistic framework for interpreting epithelial proliferation and migration in ulcerative colitis models.
-
Safe DNA Gel Stain for Spermatogenesis Workflows
2026-09-02
Safe DNA Gel Stain combines sensitive green fluorescence with blue-light-compatible imaging for safer DNA and RNA gel analysis. Its flexible in-gel and post-electrophoresis formats support cloning, RNAi validation, and reproductive-biology workflows while helping limit UV-related DNA damage.
-
I-BET151 and the Super-Enhancer Logic of Cancer
2026-09-01
I-BET151, also known as GSK1210151A, offers a pharmacological way to interrogate BET-dependent transcription in cancer biology. This article connects BET bromodomain inhibition with the super-enhancer–FOXA1–SLC7A11 axis described in prostate cancer and outlines a disciplined path from mechanistic hypothesis to translational validation.
-
AIBP-LRP2 Control of Collateral Circulation
2026-09-01
Zhu et al. identify an AIBP-LRP2-HDL-miR-223 pathway that suppresses CXCR4-positive, stemlike capillary endothelial cells during ischemic vascular remodeling. The study supports a two-phase model in which these cells expand before adopting arterial identities, offering a mechanistic framework for therapeutic collateral-vessel growth.
-
Gemcitabine: Mechanism, Evidence, and Workflows
2026-08-31
Gemcitabine is a DNA synthesis inhibitor that creates replication stress and supports cancer research on checkpoint signaling and apoptosis. Product data and a 2025 cholangiocarcinoma study connect its use to cell-based assays, murine models, and chemotherapy-sensitization research.